Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings

Abhishek Paul, Nirmita Dutta, Despina Moschou, Gorachand Dutta

Research output: Contribution to journalReview articlepeer-review

1 Citation (SciVal)

Abstract

Tuberculosis (TB) is still considered a deadly disease, ranked 10th in the top 10 list of lethal diseases worldwide. But the drug-resistant form of TB is more fatal and complex. It is evident that such drug-resistant TB should be detected as early as possible so that the doctors can provide accurate and effective treatment to the infected patient, and thus prevent transmission. Many diagnostic methods for different types of drug-resistant TB have been developed, some of which are approved by WHO, while some are not. The following review highlights different methods for the rapid, accurate and sensitive detection of drug-resistant TB (DR-TB) and also discusses the potential of those methods for point-of-care (POC) application.

Original languageEnglish
Article number100036
JournalSensors International
Volume1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • Biosensor
  • Drug-resistant
  • Microfluidic
  • Point-of-care
  • Tuberculosis

ASJC Scopus subject areas

  • Electrochemistry
  • Chemistry (miscellaneous)
  • Bioengineering
  • Chemical Health and Safety
  • Materials Science (miscellaneous)
  • Electrical and Electronic Engineering

Fingerprint

Dive into the research topics of 'Advanced integrative sensing technologies for detection of drug-resistant tuberculosis in point-of-care settings'. Together they form a unique fingerprint.

Cite this